Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) EPS (Basic) (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed EPS (Basic) for 6 consecutive years, with -$5.35 as the latest value for Q4 2021.

  • Quarterly EPS (Basic) fell 2331.82% to -$5.35 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$5.55 through Dec 2021, down 545.35% year-over-year, with the annual reading at -$8.93 for FY2025, 84.32% up from the prior year.
  • EPS (Basic) for Q4 2021 was -$5.35 at ENDRA Life Sciences, down from -$0.06 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.06 in Q1 2021, with the low at -$5.35 in Q4 2021.
  • Average EPS (Basic) over 5 years is -$0.67, with a median of -$0.34 recorded in 2019.
  • The sharpest move saw EPS (Basic) soared 82.96% in 2017, then plummeted 2331.82% in 2021.
  • Over 5 years, EPS (Basic) stood at -$0.65 in 2017, then surged by 56.92% to -$0.28 in 2018, then crashed by 328.57% to -$1.2 in 2019, then surged by 81.67% to -$0.22 in 2020, then tumbled by 2331.82% to -$5.35 in 2021.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$5.35, -$0.06, and -$0.08 for Q4 2021, Q3 2021, and Q2 2021 respectively.